Logo
  1. IR@JU
  2. Ph.D. Thesis
  3. Faculty Council of Engineering & Technology
  4. 2025 (Awarded Year)
Please use this identifier to cite or link to this item: http://20.198.91.3:8080/jspui/handle/123456789/9783
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorMaity, Tapan Kumar, guide-
dc.contributor.authorMaji, Avik-
dc.date.accessioned2026-04-22T08:39:05Z-
dc.date.available2026-04-22T08:39:05Z-
dc.date.issued2025-
dc.date.submitted2025-
dc.identifier.otherTC4518-
dc.identifier.urihttp://20.198.91.3:8080/jspui/handle/123456789/9783-
dc.descriptionSupervisor(s): Maity, Tapan Kumar (Dept. of Pharmaceutical Technology, J.U.); Awarded year: 2025en_US
dc.format.extentxxvii, 275 p.en_US
dc.language.isoenen_US
dc.publisherJadavpur University, Kolkata, West Bengalen_US
dc.subject1,3,4-thiadiazoleen_US
dc.subject1,3-thiazolidine-4-oneen_US
dc.subjectAnticanceren_US
dc.subjectApoptosisen_US
dc.subjectAngiogenesisen_US
dc.titleSynthesis and in vitro anticancer activity of 1,3,4-thiadiazole and 1,3-thiazolidine-4-one scaffold-based heterocyclic moleculesen_US
dc.typeTexten_US
dc.departmentJadavpur university. Department of Pharmaceutical Technologyen_US
Appears in Collections:2025 (Awarded Year)

Files in This Item:
File Description SizeFormat 
PhD Thesis (Pharmaceutical Technology) Avik Maji.pdf21.64 MBAdobe PDFView/Open
Abstract Avik Maji.pdf100.53 kBAdobe PDFView/Open
Show simple item record


Items in IR@JU are protected by copyright, with all rights reserved, unless otherwise indicated.